Form D · Biotechnology
Celnyx, Inc.
Destin, FL · CIK 0001469279
Offering snapshot reported Aug 21, 2009 · SEC filing
- Reported sold
- $3M Offering amount: $4.5M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Aug 6, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2009 | Initial | $3,000,000 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 05, 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $200K
- Form D file number
- 021-133856
Mr. Lyons is receiving 200,000 shares of the common stock of Issuer, which is valued at $1.00 per share in the Offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jason Lyons | None |
Source: Form D, filed Aug 21, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas R. Becnel | Director, Executive |
| Steve Gorlin | Director, Executive |
| Dr. Kwang Kook Kim | Director |
| Dr. Woo Chul Moon | Director, Executive |
| Parker H. Petit | Director |
| William Spier | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1234 Airport Road Suite 105
Destin, FL, 32541
Destin, FL, 32541